Category Archives: pharma

Blockchain in Healthcare: A Vehicle Towards Digital Health 2.0?

Posted on March 26, 2018 by David Lee Scher, MD

I would like to apologize to the readers of this site for the long hiatus. I have been spending time as cardiologist, consultant, and caregiver for a seriously ill family member.  My goal is to continue writing as it is … Continue reading →

Posted in #digitalhealth, clinical trials, digital health, digital health technology, drug addiction, FDA, healthcare economics, Healthcare IT, IT security, medical apps, medical devices, patient engagement, patient safety, pharma, technology | Tagged , , , , , , , , , | 5 Comments

Five Public Health Needs for Digital Health Technology

Posted on November 28, 2016 by David Lee Scher, MD

  Digital health technology has seen an incredible growth in the last few years, fueled by a combination of consumerization of wearable technologies,  ubiquity of mobile devices, proliferation of technology incubators, attention by government health and regulatory agencies and involvement … Continue reading →

Posted in #digitalhealth, digital health, digital health technology, education, FDA, fitness, healthcare economics, healthcare reform, medical apps, medical devices, mHealth, mobile health, patient advocacy, patient engagement, pharma, remote patient monitoring, technology, telehealth, wireless health | Tagged , , , , , , , , , , , | 4 Comments

Five Reasons Why Digital Health Needs Patient Reported Outcomes

Posted on September 1, 2016 by David Lee Scher, MD

According to the National Quality Forum, patient reported outcomes or patient reported outcomes measures (PROs) can be defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s … Continue reading →

Posted in #digitalhealth, analytics, clinical trials, digital health, EHR, FDA, healthcare economics, Healthcare IT, healthcare reform, informatics, medical apps, mHealth, mobile health, patient engagement, pharma, remote patient monitoring, technology, telehealth | Tagged , , , , , , , , , , , , , | Leave a comment

Five Reasons We Must Untrap Digital Health’s Big Data

Posted on July 28, 2016 by David Lee Scher, MD

We tend to think of Big Data as a Land of Oz where we can find any information we need. What is not appreciated by most in healthcare is that there is a lot of Big Data collected but most … Continue reading →

Posted in #digitalhealth, analytics, digital health, digital health technology, EHR, healthcare economics, Healthcare IT, medical apps, medical devices, mHealth, mobile health, pharma, technology, telehealth | Tagged , , , , , , , , | 2 Comments

My Five Asks of Digital Health

Posted on April 29, 2016 by David Lee Scher, MD

Digital health is experiencing what I would characterize as its adolescence.  The rudimentary pieces are in place for adoption; Awareness of the technologies, the progressing maturation of mobile technologies, realization of its critical need in the marketplace, interest by large … Continue reading →

Posted in #digitalhealth, analytics, digital health, digital health technology, EHR, fitness, healthcare economics, Healthcare IT, healthcare reform, healthcare vendors, informatics, medical apps, medical devices, mHealth, mobile health, patient advocacy, patient engagement, pharma, smartphone apps, technology, telehealth | Tagged , , , , , , , , , , , , , | 1 Comment

Five Requirements for the Adoption of Genomics as a Digital Health Tool

Posted on October 16, 2015 by David Lee Scher, MD

That digital health technologies will be adopted to address the ills of healthcare systems around the world is a foregone conclusion. The challenges of the cost of chronic disease burden, physician and patient dissatisfaction While awareness of digital health is … Continue reading →

Posted in clinical trials, digital health, digital health technology, education, FDA, Healthcare IT, informatics, medical apps, medical devices, mHealth, mobile health, pharma, remote patient monitoring, technology | Tagged , , , , , , , , , , , , , | 4 Comments

Five Imperatives of the Ideal Digital Patient Education Tool

Posted on August 10, 2015 by David Lee Scher, MD

I’ve previously discussed what I consider the five imperatives of patient-centric care.  One of them was quality patient education and monitoring tools. Tools must reflect health literacy. Health literacy is defined by the Department of Health and Human Services as … Continue reading →

Posted in communications, digital health, digital health technology, EHR, medical apps, mHealth, mobile health, pharma, telehealth, wireless health | Tagged , , , , , , , | 2 Comments

Five Ways Digital Communication Tools Can Improve Health Care

Posted on May 11, 2015 by David Lee Scher, MD

Many of the problems plaguing healthcare today, specifically errors in patient care, reside in poor communications.  How many of us need to listen to the entire recorded message tree when calling a doctor’s office or healthcare facility, only to not … Continue reading →

Posted in communications, digital health technology, healthcare economics, language, patient engagement, pharma, smartphone apps, technology, telehealth | Tagged , , , , , , , , , , , | Leave a comment

Five Imperatives of User Experience (UX) Design in Mobile Health Technology

Posted on February 17, 2015 by David Lee Scher, MD

The Wiki definition of UX design is “the process of enhancing user satisfaction by improving the usability, ease of use, and pleasure provided in the interaction between the user and the product.” UX design success in mobile health technologies depends … Continue reading →

Posted in digital health, Healthcare IT, medical apps, mHealth, mobile health, patient engagement, pharma, remote patient monitoring, risk management, smartphone apps, technology, telehealth | Tagged , , , , , , , , , , | 2 Comments

Five Ways Analytics in Digital Health Tools Will Change Healthcare

Posted on February 8, 2015 by David Lee Scher, MD

There are many reasons cited why digital technologies hope to improve of patient care as well as the state of healthcare itself. They include improving efficiencies, patient safety, and cost. However, as has been seen with the most ubiquitous face … Continue reading →

Posted in analytics, digital health, healthcare economics, Healthcare IT, healthcare reform, medical devices, mHealth, mobile health, patient engagement, pharma, remote patient monitoring, sudden cardiac arrest, technology | Tagged , , , , , , , , , , , , , | 1 Comment